KEY WORD 2000-2001 膠原病

出版社： 先端医学社
著者：
発行日： 1999-10-15
分野： 臨床医学：内科  >  膠原病/リウマチ
ISBN： 9784915892875
電子書籍版： 1999-10-15 （第1版第1刷）
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

2,750 円(税込)

購入する

商品紹介

進展著しい全身性結合組織疾患領域の理解に必須の100項目を精選し、見開き2頁にわたって解説。
最先端の情報をコンパクトに整理できる好評KEY WORDシリーズ。進展著しい医学各領域における基礎から臨床の話題まで最新の動向をいち早く理解するために必要なキーワードを厳選。各分野での第一人者が見開き2頁にわたり平易に解説。トランスレーショナル・リサーチの理解の一助として医師、研究者のみならず、広く医療にかかわる方々の、より正確な知識の把握と整理のための座右の書。

目次

  • 表紙
  • 序
  • 執筆者一覧
  • 略語一覧
  • 目次
  • あ行 亜急性エリテマトーデス
  • アフェレシス療法
  • アポトーシス
  • アンチセンス
  • 一酸化窒素
  • イディオタイプネットワーク
  • インターロイキン
  • エンドセリン
  • か行 可溶性サイトカイン受容体
  • 間質性肺炎
  • 環状紅斑【シェーグレン症候群】
  • 関節炎動物モデル
  • 強皮症腎クリーゼ
  • 強皮症動物モデル
  • クリオグロブリン血症
  • 血管炎症候群
  • 血漿交換療法
  • 血栓性微少血管症性溶血性貧血
  • ケモカイン【RANTES, MCP-1】
  • 限局性強皮症
  • 抗アミノアシルtRNA合成酵素抗体
  • 抗炎症サイトカイン
  • 抗核小体抗体
  • 抗カルパスタチン抗体
  • 抗サイトカイン療法
  • 好酸球性筋膜炎【EMS】
  • 光線過敏【SPF】
  • 抗セントロメア抗体
  • 抗トポイソメラーゼI抗体
  • 抗リン脂質抗体症候群
  • 抗β2-グリコプロテインI抗体
  • 抗DNA抗体
  • 抗RNAポリメラーゼ抗体
  • 抗SS-A抗体, 抗SS-B抗体
  • 抗UI RNP抗体と抗Sm抗体
  • さ行 細胞接着分子
  • シェアードエピトープ仮説
  • シグナル伝達
  • シクロスポリン
  • シクロホスファミドパルス療法
  • 疾患標識自己抗体
  • 職業性・環境因子誘発強皮症【EMS】
  • 新生児ループス【先天性心ブロック】
  • 蕁麻疹様血管炎
  • スーパー抗原
  • 成人スチル病
  • 早期リウマチ
  • 爪上皮出血点【毛細血管顕微鏡】
  • た行 蝶形紅斑
  • トロンボモジュリン
  • な行 内在性レトロウイルス
  • 熱ショック蛋白
  • は行 肺高血圧症
  • 反応性関節炎【ライター病】
  • ヒトアジュバント病【美容外科手術後強皮症】
  • 皮膚エリテマトーデス
  • 封入体筋炎
  • フリーラジカル
  • プロテインC, プロテインS
  • 分子相同性
  • 閉塞性細気管支炎器質化肺炎
  • ま行 マトリックスメタロプロテイナーゼ
  • 無菌性骨壊死
  • 免疫複合体
  • や行 薬剤誘発ループス
  • ら行 ループス腎炎
  • ループス膀胱炎, ループス腹膜炎
  • A ACRコアセット
  • α-フォドリン
  • Amyopathic dermatomyositis
  • ANCA
  • ANCA関連血管炎【microscopic PN】
  • Antigen-driven
  • B B細胞トレランス
  • B-1細胞
  • C CNSループス【抗リボソームP抗体】
  • Costimulatory molecules
  • COX-1, COX-2
  • Cryptic epitope
  • D DMARD
  • F FasとFasリガンド【可溶性Fas】
  • FK506
  • G γ-グロブリン大量静注療法
  • H Hemophagocytic syndrome
  • HLA
  • HTLV-I関連関節症
  • I IFN
  • IL-1, TNF
  • IL-6
  • L Lyme病
  • M MCTD, UCTD
  • Microchimerism
  • N NKT細胞
  • S Scleroderma spectrum disorder
  • SLE活動性指標【SLEDAI】
  • SLE動物モデル
  • T T細胞クロナリティー
  • T細胞トレランス
  • TGF-β
  • Th1, Th2
  • 索引
  • 奥付

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

あ行 亜急性エリテマトーデス

P.11 掲載の参考文献
1) Sontheimer RD, Thomas JR, Gilliam JN:Subacute cutaneous lupus erythematosus:A cutaneous marker for discoid lupus erythematosus subset. Arch Dermatol 115:1409-1415, 1979
PubMed
2) Sontheimer RD:Subacute cutaneous lupus erythematosus:A decade's perspective. Med Clin North Am 73:1073-1090, 1989
PubMed
3) 河内山明, 植木宏明:抗SS-A抗体を示した ANA-negative SLE (subacute cutaneous LE) の1例. 臨皮 38:303-306, 1984
 
4) 渡邊孝宏, 土田哲也:膠原病でみられる環状紅斑について. 皮膚臨床 37:847-854, 1995
 
5) Provost TT, Watson R:Anti-Ro (SS-A) HLA-DR 3-positive women:the interrelationship between some ANA negative, SS, SCLE, and NLE mothers and SS/LE overlap female patients. J Invest Dermatol 100:14S-20S, 1993
 
6) Watanabe T, Tsuchida T, Ito Y et al:Annular erythema associated with lupus erythematosus/Sjogren's syndrome. J Am Acad Dermatol 36:214-218, 1997
PubMed
P.13 掲載の参考文献
1) 山路健, 津田裕士:慢性関節リウマチ (アフェレシスマニュアル) . クリニカルエンジニアリング 別冊:159-163, 1999
 
2) 津田裕士:全身性エリテマトーデス (アフェレシスマニュアル) . クリニカルエンジニアリング 別冊:164-165, 1999
 
3) 金井美紀:抗リン脂質抗体症候群 (アフェレシスマニュアル) . クリニカルエンジニアリング 別冊:166-170, 1999
 
P.15 掲載の参考文献
1) Kerr JF, Willie AH, Currie AR et al:Apoptosis:a basic biological phenomenon with wide-ranging implications in tissue kinetics. Brit J Cancer 26:239-257, 1972
 
2) 内海耕慥, 井上正康監修:アポトーシスの分子機構と病態. メディカルトリビューンブックス, 日本アクセル・シュプリンガー出株株式会社, 東京, 1996
 
3) 米原 伸, 企画構成:特集:アポトーシス. Mebio 12:16-116, 1995
 
4) Nishioka K, Hasunuma T, Kato T et al:Apoptosis in rheumatoid arthritis. Arthritis Rheum 41:1-9, 1998
PubMed
P.17 掲載の参考文献
1) Crooke ST, Bennett CF:Progress in antisense oligonucleotide therapeutics. Annu Rev Pharmacol Toxicol 36:107-29, 1996
PubMed
2) Agrawal S, Iyer RP:Perspectives in antisense therapeutics. Pharmacol Ther 76:151-160, 1997
PubMed
3) Branch AD:A good antisense molecule is hard to find. Trends Biochem Sci 23:45-50, 1998
PubMed
P.19 掲載の参考文献
1) Clancy RM, Amin AR, Abramson SB:The role of nitric oxide in inflammation and immunity. Arthritis Rheum 41:1141-1151, 1998
PubMed
2) Evans DM, Ralston SH:Nitric oxide and bone. J Bone Miner Res 11:300-305, 1996
 
3) 宮坂信之:慢性関節リウマチとNO. 別冊・医学のあゆみ, 平田結喜緒編, 医歯薬出版株式会社, 東京, 1996, pp. 238-241
 
P.21 掲載の参考文献
1) Stollar BD:The origin and pathogenic role of anti-DNA autoantibodies. Current Opinion Immunol 2:607-612, 1990
 
P.23 掲載の参考文献
1) 笠倉新平:サイトカインとは. 第二版サイトカイン改訂新版, 笠倉新平編, 日本医学館, 東京, 1997, pp. 1-10
 
2) 原田明久, 松島綱治:ケモカイン研究の新しい展開. 炎症と免疫 5:420-425, 1997
Medical*Online
P.25 掲載の参考文献
1) 柳沢正史:エンドセリンファミリー・3つのアイソペプチド遺伝子の構造と発現. 実験医 8:111-116, 1990
 
2) 荒井宏司, 吉政孝明, 高尾和彦ほか:エンドセリン受容体の構造, 機能と発現調節. 血管内皮 4:398-405, 1994
 

か行 可溶性サイトカイン受容体

P.27 掲載の参考文献
1) Fernandez-Botran R, Chilton PM, Ma Y:Soluble cytokines:Their roles in immunoregulation, disease, and therapy. Adv Immunol 63:269-336, 1996
PubMed
2) Muller-Newen G, Kohne C, Heinrich PC:Soluble receptors for cytokines and growth factors. Int Arch Allergy Immunol 111:99-106, 1996
PubMed
P.29 掲載の参考文献
1) 猪熊茂子, 伊藤健司, 小林祥子ほか:PSS100例の調査による, 厚生省強皮症調査研究班肺線症診断基準の検討. 厚生省特定疾患強皮症調査研究班平成3年度研究報告書, 1992, pp. 101-103
 
2) Inokuma S, Sakata M, Yoshida A et al:Bucillamine induced pulmonary injury occurs with immunoglobulin decrease. J Rheumatol 23:1282-1285, 1996
PubMed
P.31 掲載の参考文献
1) 臼田俊和:抗SS-A/抗SS-B抗体陽性シェーグレン症候群と再発性遠心性環状紅斑. 日臨 53:2557-2562, 1995
Medical*Online
2) Yamada C, Ichikawa Y, Horiki T et al:Clinical features of Sjogren's syndrome associated with recurrent annular erythema. Jpn J Rheum 8:225-237, 1998
 
P.33 掲載の参考文献
1) Feldmann M, Brennan FM, Maini RN:Rheumatoid arthritis. Cell 85:307-310, 1996
PubMed
2) 西城 忍, 岩倉洋一郎:サイトカインと自己免疫疾患. 免疫研究の新展開, 中山敬一, 山本一彦編, 羊土社, 東京, 1999, pp. 188-193
 
3) 西城 忍, 岩倉洋一郎:モデル動物と自己免疫疾患. 自己免疫疾患の臨床 (II), 山本一彦, 森本幾夫編, 最新医学社, 大阪, 1998, pp. 139-147
 
P.35 掲載の参考文献
1) Steen VD, Medsger TA, Osial TA et al:Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med 76:779-786, 1984
PubMed
2) Steen VD, Costantino JP, Shapiro AP et al:Outcome of renal crisis in systemic sclerosis:Relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 113:352-357, 1990
PubMed
3) Endo H, Hosono T, Kondo H:Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 21:864-870, 1994
PubMed
P.37 掲載の参考文献
1) Sollberg S, Krieg T:New aspects in scleroderma research. Int Arch Allergy Immunol 111:330-336, 1996
PubMed
2) Kasturi K, Muryoi T, Shibata S et al:Functional properties and molecular characteristics of autoantibodies associated with tight skin syndrome. Ann N Y Acad Sci 815:253-262, 1997
PubMed
P.39 掲載の参考文献
1) Tzioufas AG, Boumba DS, Skopouli FN et al:Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjogren's syndrome. Arthritis Rheum 39:767-772, 1996
PubMed
2) Aiyama T, Yoshioka K, Okuyama A et al:Hypervariable region squence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C:relationship to antibody response against hypervariable region genome. Hepatology 24:1346-1350, 1996
 
3) Koike K, Moriya K, Ishibashi K et al:Sialadenitis histologically resembling Sjogren's syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci USA 94:233-236, 1997
PubMed
P.41 掲載の参考文献
1) Savage COS, Harperl L, Adu D:Primary systemic vasculitis. Lancet 349:553-558, 1997
 
2) Jennette JC, Falk RJ:Small-vessel vasculitis. New Engl J Med 337:1512-1523, 1997
PubMed
3) Hagen EC, Daha MR, Hermans J et al:Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int 53:743-753, 1998
PubMed
P.43 掲載の参考文献
1) 広畑俊成:血液浄化療法:自己免疫疾患の臨床1998 (I). 最新医 53:788-795, 1998
 
2) Wallace DJ:Nonpharmacologic therapeutic modalities. In:Dobois' lupus erythematosus. 5th ed, ed. by Wallace DJ et al, Williams & Wilkins, Balcimere, 1997, pp. 1181-1190
 
3) 高橋孝喜:自己免疫疾患の血漿交換療法. 日臨 48:775-781, 1990
Medical*Online
P.45 掲載の参考文献
1) 市川陽一, 田中千絵, 大矢直子:SLEに合併する溶血性貧血. 日臨 54:2528-2533, 1996
Medical*Online
2) 斉藤英彦, 重松秀一, 伊藤和彦ほか:多発性細小血管血栓症. 日臨 51:5-221, 1993
 
P.47 掲載の参考文献
1) Mukaida N, Harada A, Matsushima K:Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev 9:9-23, 1998
PubMed
P.49 掲載の参考文献
1) 菊池かな子, 石橋康正, 竹原和彦:限局性強皮症における抗1本鎖DNA抗体の臨床的意義について. 皮膚臨床 31:1607-1611, 1989
 
2) Sato S, Ihn H, Soma Y et al:Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 36:1137-1141, 1993
PubMed
3) 竹原和彦, 尹 浩信, 佐藤伸一ほか:限局性強皮症における抗1本鎖DNA抗体-抗体価の推移が治療上の参考となった2例-. 皮膚臨床 35:737-740, 1993
 
P.51 掲載の参考文献
1) Nishikai M, Reichlin M:Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum 23:881-888, 1980
PubMed
2) Mimori T:Structure targeted by the immune system in myositis. Curr Opin Rheumator 8:521-527, 1996
PubMed
3) Nishikai M, Ohya K, Kosaka M et al:Anti-Jo-1 antibodies in polymyositis or dermatomyositis:Evaluation by ELISA using recombinant fusion protein Jo-1 as antigen. Br J Rheumatol 37:357-361, 1998
PubMed
P.53 掲載の参考文献
1) Rocken M, Racke M, Shevach EM:IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 17:225-231, 1996
PubMed
2) Howard M, O'Garra A:Biological properties of interleukin 10. Immunol Today 13:198-200, 1992
 
3) Pretolani M, Goldman M:IL-10:a potential therapy for allergic inflammation? Immunol Today 18:277-280, 1997
PubMed
P.55 掲載の参考文献
1) Monestier M:Nucleolar autoantibodies. In:Autoantibkdies, ed. by Peter JB, Shoenfeld Y, Elsevier, Amsterdam, 1996, pp. 567-573
 
2) Okano Y:Antinuclear antibody in systemic sclerosis (scleroderma) . Rheum Dis Clin North Am 22:709-735, 1996
PubMed
P.57 掲載の参考文献
1) Mimori T, Suganuma K, Tanami Y et al:Autoantibodies to calpastatin (an endogenous inhibitor for calciumdependent neutral protease, calpain) in systemic rheumatic diseases. Proc Natl Acad Sci USA 92:7267-7271, 1995
PubMed
2) Despres N, Talbot G, Plouffe B et al:Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera. J Clin Invest 95:1891-1896, 1995
 
3) Menard HA, EL-Amine M:The calpain-calpastatin system in rheumatoid artihritis. Immunol Today 17:545-547, 1996
PubMed
P.59 掲載の参考文献
1) Wallis WJ, Furst DE, Strand V et al:Biologic agents and immunotherapy in rheumatoid arthritis. Rheum Dis Clin N Am 24:537-565, 1998
 
2) Evans CH, Ghivizzani SC, Kang R et al:Gene therapy for rheumatic deseases. Arthritis Rheum 42:1-16, 1999
 
P.61 掲載の参考文献
1) Varga J, Kahari VM:Eosinophilia-myalgia syndrome, eosinophilic fasciitis, and related fibrosing disorders. Curr Opin Rheumatol 9:562-570, 1997
PubMed
2) Lakhanpal S, Ginsburg WW, Michet CJ et al:Eosinophilic fasciitis:clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 17:221-231, 1988
PubMed
3) Varga J, Uitto J, Jimenez SA et al:The cause and pathogenesis of the eosinophilia-myalgia syndrome. Ann Intern Med 116:140-147, 1992
PubMed
P.63 掲載の参考文献
1) Walchner M, Messer G, Kind P et al:Phototesting and photoprotection in LE. Lupus 6:167-174, 1997
PubMed
2) Furukawa F, Kanauchi H, Inamura S et al:Susceptibility to UVB light in cultured keratinocytes of cutaneous lupus erythematosus. Dermatology 189 (Suppl. 1):18-23, 1994
 
3) Furukawa F:Mechanisms of cutaneous injury in photosensitive cutaneous lupus erythematosus. In:Dermatology at the Millennium, Parthenon Publishing, Lancs, UK, 1999, pp. 278-282
 
4) Furukawa F:Antinuclear antibody-keratinocyte interactions in photosensitive cutaneous lupus erythematosus. Histol Histopathol 14:627-633, 1999
PubMed
P.65 掲載の参考文献
1) 竹原和彦:抗セントロメア抗体. 皮膚臨床 35:729-736, 1993
 
2) Muro Y, Sugimoto K, Himeno M et al:Scleroderma diagnosis with recombinant protein. In:Molecular Biology and Biotechnology, ed. by Meyers R A, VCH, New York, 1995, pp. 853-856
 
3) Rothfield N F:Autoantibodies to scleroderma-associated antigens. In:Manual of Biological Markers of Disease. C5. 1. , ed. by Venrooij W J, Maini R N, Kluwer, Dordrecht, 1996, pp. 1-7
 
P.67 掲載の参考文献
1) Kuwana M, Kaburaki J, Okano Y et al:Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 37:75-83, 1994
PubMed
2) Wang JC:DNA topoisomerases. Annu Rev Biochem 54:655-697, 1987
 
P.69 掲載の参考文献
1) 岡田 純:抗リン脂質抗体症候群の病像の多様性. 医学のあゆみ 166:587-590, 1993
Medical*Online
2) Hughes GRV:The antiphospholipid syndrome:ten years on. Lancet 342:341-344, 1994
 
3) Asherson RA:The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatment. Lupus 2 (Suppl):S55-62, 1998
 
4) 小池隆夫:抗リン脂質抗体症候群の診断と治療. 日内会誌 87:466-469, 1998
 
P.71 掲載の参考文献
1) 岡田 純:抗リン脂質抗体症候群の病像の多様性. 医学のあゆみ 166:587-590, 1993
Medical*Online
2) Kandiah DA, Krilis SA:Immunology and Methods of Dtection of Antiphospholipid Antibodies. In:The Antiphospholipid syndrome. 1st, ed. by Asherson RA et al, CRC Press, Boca Raton, 1996, pp. 29-49
 
3) Kandiah DA, Krilis SA:Anti-β 2-glycoprotein 1 and anti-prothrombin antibodies in patients with the 'antiphospholipid' syndrome:immunological specificity and clotting profiles. Lupus 7:323-332, 1998
 
P.73 掲載の参考文献
1) Radic MZ, Weigert M:Genetic stuctural evidence for antigen selection of anti-DNA antibodies. Ann Rev Immunol 12:487-520, 1994
 
2) Diamond B, Katz JB, Paul E et al:The role of somatic mutations in the pathogenic anti-DNA response. Ann Rev Immunol 10:731-757, 1992
 
3) Suzuki N, Mihara S, Sakane T:Development of pathogenic anti-DNA antibody in patients with systemic lupus erythematosus. FASEB J 11:1033-1138, 1997
PubMed
P.75 掲載の参考文献
1) Okano Y, Medsger TA Jr:RNA polymerase I-III autoantibodies. In:Autoantibodies, ed. by Peter JB, Shoenfeld Y, Elsevier, Amsterdam, 1996, pp. 727-734
 
2) Okano Y:Antinuclear antibody in systemic sclerosis (scleroderma) . Rheum Dis Clin North Am 22:709-735, 1996
PubMed
P.77 掲載の参考文献
1) Tan EM:Antinuclear antibodies:Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93-150, 1989
PubMed
2) 高崎芳成:抗核抗体. 最新内科学大系 24:34-54, 1993
 
3) McCauliffe DP, Lux FA, Lieu TS et al:Ro/SS-A and the pathogenic significance of its antibodies. J Autoimmun 2:375-381, 1989
 
P.79 掲載の参考文献
1) 三森経世:抗核抗体研究の進歩-自己抗体が認識する核および細胞質蛋白の構造と機能. リウマチ32:366-378, 1992
 
2) Tan EM:Antinuclear antibodies:Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93-151, 1989
PubMed
3) Steitz JA:SNURPS. Sci Am 256:56-63, 1988
 

さ行 細胞接着分子

P.81 掲載の参考文献
1) Humphries MJ, Newham P:The structure of cell-adhesion molecules. Trends Cell Biol 8:78-83, 1998
PubMed
2) Mojcik CF, Shevach EM:Adhesion molecules:a rheumatologic perspective. Arthritis Rheum 40:991-1004, 1997
PubMed
3) McMurray RW:Adhesion molecules in autoimmune disease. Semin Arthritis Rheum 25:215-233, 1996
PubMed
P.83 掲載の参考文献
1) Gregersen PK, Silver J, Winchester RJ:The shared epitope hypothesis, an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205-1213, 1987
PubMed
2) Nepom BS, Nepom GS:Polyglot and polymorphism, an HLA update. Arthritis Rheum 38:1715-1721, 1995
 
3) Wucherpfenning KW, Strominger JL:Selective bindng of self peptides to disease-associated major histcompatibility complex (MHC) Molecules:A mechanism for MHC-linked susceptibility to human autoimmune diseases. Cell 181:1597-1601, 1995
 
P.85 掲載の参考文献
1) Salojin KV, Zhang J, Madrenas J et al:T-cell anergy and altered T-cell receptor signaling:Effects on autoimmune disease. Immnnol Today 19:468-473, 1998
 
2) 竹内 勤:リンパ球シグナル伝達の異常. 日内会誌 87:2446-2453, 1999
 
P.87 掲載の参考文献
1) Schreiber SL, Crabtree GR:The mechanism of action of cyclosporin A and FK506. Immunology Today 13:136-142, 1992
PubMed
2) Hess AD:Cellular immunobiology of cyclosporin A In:Immunosuppressive Drugs, ed. by Thomson AW, Starzl T, Edward Arnold, London, 1994, pp. 47-62
 
P.89 掲載の参考文献
1) Austin HA, Klippel JH, Balow JE et al:Therapy of lupus nephritis:Controlled trial of prednisolone and cytotoxic drugs. N Engl J Med 314:614-619, 1986
 
2) Kunis CL, Kiss B, Williams G et al:Intravenous"pulse"cyclophosphamide therapy of crescentic glomerulonephritis. Clin Nephrol 37:1-7, 1992
PubMed
3) Gourley MF, Austin HA, Scott D et al:Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. Ann Int Med 125:549-557, 1996
PubMed
P.93 掲載の参考文献
1) Tan EM:Antinuclear antibodies:Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93-151, 1989
PubMed
2) 平形道人:抗核抗体の多様性と疾患特異性. 内科80:22-28, 1997
 
3) Tan EM, Cohen AS, Fries JF et al:The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthrities Rheum 25:1271-1277, 1982
 
P.95 掲載の参考文献
1) Haustein UF, Ziegler V:Enviromentally induced systemic sclerosis-like disorders. Int J Dermatol 24:147-151, 1985
 
2) Silver RM, Heyes MP, Maize JC et al:Scleroderma, Fasciitis, and eosinophilia associated with ingestion of tryptophan. N Engl J Med 322:874-881, 1990
PubMed
P.97 掲載の参考文献
1) Tseng C-E, Buyon Jp:Neonatal lupus syndromes. Rheum Dis Clin North Am 23:31-54, 1997
PubMed
2) Silverman ED, Laxer RM:Neonatal lupus erythema-tosus. Rheum Dis Clin North Am 23:599-618, 1997
 
3) 福本隆也, 宮川幸子, 篠原康二ほか:新生児エリテマトーデス . 皮膚臨床 39:1009-1014, 1997
 
4) Shinohara K Miyagawa S, Fujita T et al:Neonatal lupus erythematosus:Results of maternal corticosteroid therapy. Obset Gynecol, 1999, in press
 
P.99 掲載の参考文献
1) 川名誠司:蕁麻疹様血管炎 (urticarial vasculitis). MB Derma 16:51-56, 1998
 
2) 宮地良樹:unicarial vasculitis. 膠原病-診断と治療の最新ポイント, 宮地良樹, 竹原和彦編, 診断と治療社, 東京, 1997, pp. 132-133
 
P.101 掲載の参考文献
1) 内山竹彦:細菌性スーパー抗原と細菌感染症の発症機序. 炎症 15:429-438, 1995
 
2) 菅原俊二, 熊谷勝男:スーパー抗原と免疫学的疾患. アレルギー 45:435-441, 1996
Medical*Online
3) 戸倉新樹:スーパー抗原としての黄色ブドウ球菌毒素, 皮膚での反応. 皮膚 40:32-38, 1998
 
4) 古川福実:スーパーアンチゲン. 皮病診療 20:203-209, 1998
 
P.103 掲載の参考文献
1) 大田明英:成人スチル病-最近の知見-. 医学のあゆみ 182:687-692, 1997
 
2) Ohta A, Yamaguchi M, Tsunematsu T et al:Adult Still's disease:A multicenter survey of Japanese patients. J Rheumatol 17:1058-1063, 1990
PubMed
3) Yamaguchi M, Ohta A, Tsunematsu T et al:Preliminary criteria for classification of adult Still's disease. J Rheumatol 19:424-430, 1992
 
P.105 掲載の参考文献
1) Higami K, Hakoda M, Matsuda Y et al:Lack of association of HLA-DRBI genotype with radiologic progression in japanese patients with early rheumatoid arthritis. Arthritis Rheum 40:2241-2247, 1997
 
2) Matsuda Y, Yamanaka H, Higami K et al:Time lag between active joint inflammation and radiological progression in patients with early rheumatoid arthritis. J Rheum 25:427-432, 1998
PubMed
3) Mottonen T, Paimela L, Ahonen J et al:Outcome in patients With early rheumatoid arthritis treated according to the"sawtooth"strategy. Arthritis Rheum 39:996-1005, 1996
 
P.107 掲載の参考文献
1) Sato S, Takehara K, Soma Y et al:Diagnostic signhicance of nailfold bleeding in scleroderma spectrum disorders. J Am Acad Dermatol 28:198-203, 1993
PubMed
2) 竹原和彦:汎発性強皮症の早期診断. 臨皮45:121-126, 1991
 

た行 蝶形紅斑

P.109 掲載の参考文献
1) Wallace DJ:Cutaneous manifestations of SLE. In:Dubois' lupus erythematosus, 4th ed, ed. by Wallace DJ, Hahn BH, Lea & Febiger, Philadelphia, 1993, pp. 356-359
 
P.111 掲載の参考文献
1) 小山高敏:トロンビン-トロンボモジュリン-プロテインCと血管内皮の反応. 血液・腫瘍科 32:481-489, 1996
 
2) 櫻川信男:トロンボモジュリン (TM). 日本臨床1995 年増刊号 広範囲血液・尿化学検査, 免疫学的検査 (中巻). 53 (Su Pt 2):132-136, 1995
 
3) 岡本好司, 日暮愛一郎, 轟木秀一ほか:DICと集中治療-DIC治療の新しい考え方-トロンボモジュリンとプロテインC. 集中治療8:1355-1360, 1996
 
4) Alarcon-Segovia D, Cabral AR:The concept and classification of antiphospholipid/cofactor syndromes. Lupus 5:364-367, 1996
PubMed
5) Cucurull E, Gharavi AE:Thrombomodulin:a new frontier in lupus research? Clin Exp Rheumatol 15:1-4, 1997
PubMed

な行 内在性レトロウイルス

P.113 掲載の参考文献
1) Leib-Mosch C, Brack-Werner R, Werner T et al:Endogenous retroviral elements in human DNA Cancer Res 50:5636S-5642S, 1993
 
2) Nakagawa K, Harrison LC:The potential roles of endogenous retroviruses in autoimmunity. Immunol Rev 152:193-236, 1996
PubMed
3) Sekigawa I, Kaneko H, Hishikawa T et al:HIV infection and SLE:their pathogenic relationship. Clin Exp Rheumatol 16:175-180, 1998
PubMed
P.115 掲載の参考文献
1) 簑田清次:自己免疫疾患とストレス蛋白質. 臨病理 45:19-26, 1997
 
2) 長田重一:アポトーシス:生死の実権をにぎる分子たち. 実験医16:1242-1246, 1998
 
3) Arrigo A:Small stress proteins:Chaperones that act as regulators of intracellular redox state and programmed cell death. Biol Chem 379:19-26, 1998
 

は行 肺高血圧症

P.117 掲載の参考文献
1) 西間木友衛:肺高血圧症の臨床-主として膠原病-. リウマチ科 8:47-53, 1992
 
2) 国枝武義:肺高血圧症の臨床-主として原発性肺高血圧症-. リウマチ科 8:54-65, 1992
 
P.119 掲載の参考文献
1) Fan PT, Yu DTY:Reiter's syndrome. In:The Textboole Of Rheumatology, 4th ed, ed. by Kelly WN, Harris ED, Ruddy S, Sledge CB, W. B. Sauders Company, Philadelphia, 1993, pp. 961-973
 
2) Cush JJ, Lipsky PE:Reiter's syndrome and reactive arthritis. In:Arthritis and allied conditions, ed. by McCarty DJ, Koopman WJ, Lea & Febigen, Philadelphia, 1993, pp. 1061-1078
 
3) Fink CW:The role of the Streptococcus in poststreptococcal reactive arthritis and childhood polyarteritis nodosa. J Rheumatol 18 (suppl 29):14-20, 1991
 
4) 小林茂人:反応性関節炎-最近の知見. 日内会誌 87:1389-1394, 1998
 
5) Hammer RE, Maika SD, Richardson JA et al:Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and humanβ2-m:An animal model of HLA-B27-associated human disorders. Cell 63:1099-1112, 1990
 
P.121 掲載の参考文献
1) 三好和男:人アジュバント病. 臨床科学 28:661-673, 1992
 
2) Sanchez-Guerrero J, Schur PH, Sergent JS et al:Silicone breast implants and rheumatic disease. Arthritis Rheum 37:158-168, 1994
PubMed
3) 竹原和彦:美容外科手術後強皮症. 皮膚臨床35:369-374, 1993
 
P.123 掲載の参考文献
1) 土田哲也:エリテマトーデスの病型. MB Derma 5:9-17, 1997
 
P.125 掲載の参考文献
1) 村上信行, 埜中征哉:Rimmed vacuoleの筋病理. 神経内科 43:104-111, 1995
 
2) Lotz BP, Engel AG, Nishino H et al:Inclusion body myositis, observations in 40 patients. Brain 112:727-747, 1989
PubMed
P.127 掲載の参考文献
1) Halliwell B, Gutteridge JM, Cross CE:Free radicals, antioxidants, and human disease:Where are we now? J Lab Clin Med 119:598-620, 1992
PubMed
2) 吉川敏一:フリーラジカルの科学. 講談社サイエンティフィック, 東京, 1997
 
3) 吉川敏一, 谷川徹:活性酸素とRA. リウマチ科 17:216-224, 1997
 
P.129 掲載の参考文献
1) Ginsberg JS, Demers C, Brill EP et al:Acquire free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus. Am J Med 98:379-383, 1995
 
2) Petri M:Pathogenesis and treatment of the antiphospholipid antibody syndrome. Med Clin North Am 81:151-177, 1997
PubMed
3) Lenk N, Ozet G, Alli N et al:Protein C and protein S activities in Behcet's disease as risk factors of thrombosis. Int J Dermatol 37:124-125, 1998
PubMed
4) Guermazi S, Hamza M, Dellagi K:Protein S deficiency and antibodies to protein S in patients with Behcet's disease. Thromb Res 86:197-204, 1997
PubMed
P.131 掲載の参考文献
1) Query CC, Keene JD:A human autoimmune protein associated with U1 RNA contains a resion of homology that is cross-reactive with retrovairal P30gag antigen. Cell 51:211-220, 1987
 
2) 高崎芳成:抗核抗体の対応抗原の分子生物学. 内科 80:15-21, 1997
 
3) Takasaki Y, Yano T, Hirokawa K et al:An Epitope on Ki antigen recognized by autoantibodies from lupus patients shows homology with SV40 large T antigen nuclear localization signal. Arthritis Rheum 39:855-862, 1996
PubMed
P.133 掲載の参考文献
1) 猪熊茂子:慢性関節リウマチにおける閉塞性細気管支炎. リウマチ 22:164-167, 1982
 
2) Epler G:Bronchiolitis obliterans organizing pneumonia. Definition and clinical features. Chest 102 (Suppl):2S-6S, 1992
 
3) 猪熊茂子:金療法による肺病変とリウマトイド肺. リウマチ科 1:352-357, 1989
 
4) Inokuma S, Sakata M, Yoshida A et al:Bucillamine induced pulmonary injury occurs with immunoglobulin decrease. J Rheumatol 23:1282-1285, 1996
PubMed
5) 猪熊茂子, 生馬敏行, 井上普吉ほか:ブシラミン治療下における肺障害の検討. リウマチ 36:34-42, 1996
 

ま行 マトリックスメタロプロテイナーゼ

P.135 掲載の参考文献
1) 岡田保典:MMP研究の動向. リウマチ科 20:527-534, 1998
 
2) Vincenti MP, Clark IM, Brinckerhoff CE:Using inhibitors of metalloproteinases to treat arthritis. Arthritis Rheum 77:1115-1126, 1994
 
P.137 掲載の参考文献
1) 小林茂人, 橋本博史:SLEにみられる骨壊死. リウマチ科 8:314-319, 1992
 
2) 東島利夫:SLEにおける大腿骨頭壊死症. 膠原病の難治性病態 (別冊・医学のあゆみ), 宮坂信之編, 医歯薬出版株式会社, 東京, 1996, pp. 96-100
 
3) 松野博明:大腿骨頭壊死 (注意すべき膠原病の難治性病態とその治療). 内科 83:105-109, 1999
 
4) Hirota Y, Hirohata T, Fukuda K et al:Association of alcohol intake, cigarette smoking, and occupational status with the risk of idiopathic osteonecrosis of the femoral head. Am J Epidemiol 137:530-538, 1993
PubMed
P.139 掲載の参考文献
1) 粕川禮司:免疫複合体の理解. 解説臨床免疫学, 広瀬俊一編, 科学評論社, 東京, 1987, pp 245-265
 
2) Takahashi M, Takahashi S, Hirose S:Solubilization of antigen-antibody complexes:A new function of complement as a regulator of immune reaction. Prog Allergy 27:134-166, 1980
PubMed
3) Shur PH:Complement and immune complexes in systemic lupus-erythematosu. In:Dubois Lupus Erythematosus, 3rd ed, ed. by Walace DJ, Dubois EL, Lea and Febiger, Philadelphia, 1987, pp. 185-204
 

や行 薬剤誘発ループス

P.141 掲載の参考文献
1) Paine R:Procainamide hydrochlolide and lupus eryhthematosus. JAMA 194:123-126, 1965
 
2) Nordstrom DM, West SG, Rubin RL:Methyldopa-induced systemic lupus erythematosus. Arthritis Rheum 32:205-208, 1989
PubMed
3) Portanova JP, Arndt RE, Tan EM et al:Anti-histone antibodies in indiopathic and drug-induced lupus recogniza distinct regions. J Immunol 138:446-451, 1987
 
4) Hardin JA, Craft JE:Patterns of autoimmunity to nucleoproteins in patients with systemic lupus erythematosus. Rheum Dis Clin North Am 13:37-46, 1987
PubMed

ら行 ループス腎炎

P.143 掲載の参考文献
1) 湯村和子:ループス腎炎における血漿交換療法の有用性. 日アフェレシス会誌 16:372-378, 1997
 
2) 湯村和子, 内田啓子, 川嶋朗ほか:ループス腎炎の進展への対策と治療の実際. Medical Practice 16:75-80, 1999
Medical*Online
P.145 掲載の参考文献
1) Koike T, Takabayashi K:Lupus Cystitis in the Japanese. Internal Med 35:87-88, 1996
 
2) 高林克日己, 小池隆夫:ループス膀胱炎. 医学のあゆみ 173:53-56, 1995
 
3) Nakauchi Y, Suehiro T, Tahara K et al:Systemic hlpus erythematosus relapse with lupus cystitis. Clin Exp Rheumatol 13:645-648, 1995
 

A ACRコアセット

P.147 掲載の参考文献
1) Felson DT, Anderson JJ, Boers M et al:The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trial. Arthritis Rteum 36:729-740, 1993
PubMed
2) Felson DT, Anderson JJ, Boers M et at:American college of rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38:727-735, 1995
 
3) 近藤啓文:慢性関節リウマチの活動判定 (ACRコアセットなど). リウマチ 37:825-831, 1997
 
P.149 掲載の参考文献
1) Hayashi Y:The immunology of Sjogren's syndorme:Emphasis on the role of salivary gland autoantigen, Biomed Rev 9:131-141, 1998
 
2) 林良夫, 柳久美子, 羽地則雄:Sjogren 症候群の新たな自己抗原. 最新医学 53:41-50, 1998
 
3) 林 良夫:シェーグレン症候群における臓器特異的自己抗原の同定. 生化学 70:381-385, 1998
 
P.151 掲載の参考文献
1) Euwer RL, Sontheimer RD:Amyopathic dermatomyositis:A review. J Invest Dermatol 100:124S-127S, 1993
PubMed
2) 相馬良直, 中村嘉男:Amyopathic dermatomyositis:9年間経過観察した1例とその概念をめぐる一考察. 皮膚臨床 39:1777-1782, 1997
 
P.153 掲載の参考文献
1) Hoffman GS, Specks U:Antineutrophil cytoplasmic antibodies. Arth Rheum 41:1521-1537, 1998
 
2) Jennette JC, Falk RJ:Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis. Nephrol Dial Transplant 13:16-20, 1998
PubMed
3) 吉田雅治:ANCA 関連血管炎症候群. リウマチ科 19:575-586, 1998
 
P.155 掲載の参考文献
1) Jennette JC, Falk RJ:Small-vessel vasculitis. N Engl J Med 337:1512-1523, 1997
PubMed
2) Schimitt WH, Gross WL:Vasculitis in the seriously ill partients:Diagnosic approaches and therapeutic options in ANCA-associated vasculitis. Kidney Int 64:S39-S44, 1998
 
3) 吉田雅治:ANCA関連血管炎症候群. リウマチ科 19:575-586, 1998
 
P.157 掲載の参考文献
1) 高崎芳成:抗核抗体の対応抗原の分子生物学. 内科 80:15-21, 1997
 
2) Takasaki Y, Yano T, Hirokawa K et al:An Epitope on Ki antigen recognized by autoantibodies from lupus patients shows homology with SV40 large T antigen nuclear localization signal. Arthritis Rheum 39:855-862, 1996
PubMed
3) 高崎芳成:病態, 膠原病・アレルギー学. 日医新報 3797:9-11, 1997
 

B B細胞トレランス

P.159 掲載の参考文献
1) Goodnow CC:Tramsgenic mice and analysis of B-cell tolerance. Annu Rev Immunol 10:489-518, 1992
PubMed
2) Goodnow CC:Balancing immunity and tolerance:deleting and tuning lyphocyte repertoires. Proc Natl Acad Sci USA 93:2264-2271, 1996
 
3) Healy JI, Goodnow CC:Positive versus negative signaling by lymphocyte antigen receptors. Annu Rev Immunol 16:645-670, 1998
PubMed
P.161 掲載の参考文献
1) Hardy RR, Carmack CE, Hayakawa K et al:Distinctive developmental origins and spechicities of murine CD5+B cells. Immunol Rev 137:91-118, 1994
PubMed
2) Kasaian MT, Casali P:B-1 cellular origin and VH segment structure of IgG, IgA, and IgM anti-DNA autoantibodies in patients with systemic lupus erythematosus. Ann NY Acad Sci 764:410-423, 1995
PubMed
3) Stall AM, Wells SM, Lam KP:B-1 cells:unique origins and functions. Semin Immunol 8:45-59, 1996
PubMed

C CNSループス【抗リボソームP抗体】

P.163 掲載の参考文献
1) Teh LS, Isenberg DA:Antiribosomal P protein antibodies in systemic lupus erythematosus:a reappraisal. Arthritis Rheum 37:307-315, 1994
PubMed
2) 広畑俊成:膠原病:難治性病態とその対応. 膠原病の神経, 血管病変とその対応-CNSループス. 日内会誌 85:1816-1821, 1996
 
P.165 掲載の参考文献
1) Trivol EA, Boniello F, Schweitzer AN et al:Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541-547, 1995
 
2) 安部 良:T細胞の抗原認識と接着分子. 臨床免疫 30 (Suppl. 18):131-139, 1998
 
3) Datta SK, Kalled SL:Review:CD40-CD40 ligand interaction in autoimmune disease. Arthritis Rheum 40:1735-1745, 1997
PubMed
4) Abe K, Takasaki Y, Ushiyama C et al:Expression of CD80 and CD86 on peripheral blood T lymphocytes in patients with systemic lupus erythematosus. J Clin Immunol 19:58-66, 1999
 
P.167 掲載の参考文献
1) Vane J:Towards a better aspirin. Nature 367:215-216, 1994
PubMed
2) Frolich JC:A classification of NSAIDs accordilg to the relative inhibition of cyclooxygenase isoenzymes. Trends Pharmacol Sci 18:30-34, 1997
 
3) Kawai S:Cyclooxygenase selectivity and the risk of gastrointestinal complications of various nonsteroidal anti-inflammatory drugs:a clinical consideration. Inflamm Res 47 (Supple 2):S102-S106, 1998
 
4) 川合眞一:COX-2選択的阻害薬. 炎症と免疫 7:313-320, 1999
Medical*Online
P.169 掲載の参考文献
1) Sercarz EE, Lehmann PV, Ametani A et al:Dominance and cripticity of T cell antigenic determinants. Annu Rev Immunol 11:729-766, 1993
 
2) Sercarz EE:Immune focusing vs diversification and their connection to immune regulation. Immunol Rev 164:5-10, 1998
PubMed
3) Mamula MJ:Epitope spreading:the role of self peptides and autoantigen processing by B lymphocytes. Immunol Rev 164:231-239, 1998
 
4) Warnock MG, Goodacre JA:Cryptic T-cell epitopes and their role in the pathogenesis of autoimmune diseases. Brit J Rheumatol 36:1144-1150, 1997
 

D DMARD

P.171 掲載の参考文献
1) 柏崎禎夫, 岡崎健:慢性関節リウマチの治療. 南江堂, 東京, 1988
 
2) 山中 寿, 松田祐子, 柏崎禎夫:エビデンスに基づく内科系疾患の治療戦略:慢性関節リウマチ. 内科 79:1394-1397, 1997
 

F FasとFasリガンド【可溶性Fas】

P.173 掲載の参考文献
1) 米原 伸編:アポトーシス研究の新展開. 東京化学同人, 東京, 1997
 
2) Nishioka K, Hasunuma T, Kato T et al:Apoptosis in Rheumatoid Arthritis. Arthritis Rheum 41:1-9, 1998
PubMed
3) Martin DA, Zheug L, Siegel RM et al:Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. Proc Natl Acad Sci USA 96:4552-4557, 1999
 
P.175 掲載の参考文献
1) Schreiber SL, Crabtree GR:The mechanism of action of cyclosporin A and FK506. Immunol Today 13:136-142, 1992
PubMed
2) Kahan BD:Immunosuppressive agents acting upon lymphokine synthesis and signal transduction. Clin Transplant 7:113-125, 1993
 
3) 両角国男, 福田道雄, 宇佐美武ほか:タクロリムスの内科疾患への応用と展望. 腎と透析 43:631-635, 1997
 
4) 江口勝美, 右田清志:あらたな免疫抑制剤-FK506, ラパマイシンなど-. 医学のあゆみ 189:652-656, 1997
 

G γ-グロブリン大量静注療法

P.177 掲載の参考文献
1) Kaveri SV, Mouthon L, Kazatchking MD:Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases. J Neurol Neurosurg Psychiatry 57 (Supple):6-8, 1994
 
2) Zhiya Y, Lennon VA:Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. New Engl J Med 340:227-228, 1999
 
3) Cherin P, Herson S:Indication for intravenous gammaglobulin therapy in inflammatory myopathies. J Neurol Neurosurg Psychiatry 57(Suppl):50-54, 1994
PubMed

H Hemophagocytic syndrome

P.179 掲載の参考文献
1) 今宿晋作:血球貧食症候群の概念変遷. 小児内科 28:1575-1580, 1996
 
2) 生島聡, 日比成美, 今宿晋作:小児科領域における hemophagocytic symdrome に関する全国アンケート調査. 日小血会誌 6:560-568, 1992
 
3) Wong KF, Hui PK, Chan JKC et al:The acute lupus hemophagocytic syndrome. Ann Int Med 114:387-390, 1991
 
P.181 掲載の参考文献
1) 竹内二士夫:HLAと疾患感受性. 免疫Immuno Front 7:245-251, 1997
 
2) 竹内二士夫:RA の遺伝要因としての MHC. 臨免疫 29:155-161, 1997
 
3) 竹内二士夫:膠原病と human leukocyte antigen. 日内会誌 87:73-80, 1998
 
P.183 掲載の参考文献
1) Yamashita I, Katamine S, Moriuchi R et al:Transactivation of the human interleukin-6 gene by human T-lymphotropic virus type 1 Tax protein. Blood 84:1573-1578, 1994
PubMed
2) Nishioka K, Mauryama I, Saro K et al:Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1:441, 1989
 
3) Eguchi K, Origuchi T, Takashima H et al:High seroprevalance of anti-HTLV-I antibody in rheumatoid arthritis. Arthritis Rheum 239:463-466, 1996
 
4) Sakai M, Eguchi K, Terada K et al:Infection of human synovial cells by human T cell lymphotropic virus type I. J Clin Invest 92:1957-1966, 1993
 
5) Kitajima I, Hanyu N, Kawahara K et al:Ribozyme-based gene cleavage approach to chronic arthritis associated with human T cell leukemia virus type-I. Arthritis Rheum 40:2118-2127, 1997
PubMed
6) Iwakura Y, Tosu M, Yoshida E et al:Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 253:1026-1028, 1991
PubMed
7) Kawakami A, Nakashima T, Sakai H et al:Interaction between NF-KB and caspases:Inactivation of NF-KB induces apoptosis through activation of the caspase cascade, and protective effecta mediated by HTLV-I Tax. Blood, 1991, in press
 

I IFN

P.185 掲載の参考文献
1) Taniguchi T, Lamphier MS, Tanaka N:IRF-1:the transcription factor linking the interferon response and oncogenesis. Biochem Biophys Acta 1333:M9-M17, 1997
PubMed
2) Marie I, Durbin JE, Levy DE:Differential viral induction of distinct interferon-α genes by positive feedback through interferon regulatory factor-17. EMBO J 17:6660-6669, 1998
 
3) Harada H, Kondo T, Ogawa S et al:Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation. Oncogene 9:3313-3320, 1994
PubMed
4) Tokano Y, Morimoto S, Kaneko H et al:Levels of IL-12 in the sera of patients with systemic lupus erythematosus-relation to Th1-and Th2-derived cytokine Clin Exp Immunol 116:173, 1999
 
P.187 掲載の参考文献
1) Rosenwasser LJ:Biologic activities of IL-1 and its role in human disease. J AIIergy Clin Immunol 102:344-350, 1998
 
2) Malek NP, Pluempe J, Kubicka S et al:Molecular mechanisms of TNF receptor-medicated signaling. Recent Results Cancer Res 147:97-106, 1998
 
3) Krammer PH:CD95-mediated apoptosis:Live and let die. In:Advances in Immunology, ed. by Dixon FJ, Academic Press, San Diego, 1999, pp. 163-210
 
P.189 掲載の参考文献
1) Akira S, Taga T, Kshimoto T:Interleukin-6 in Biology and Medicine. Adv Immunol 54:1-78, 1993
 
2) Kishimoto T, Akira S, Narazaki M et al:Interleukin-6 family of cytokines and gp130. Blood 86:1243-1254, 1995
PubMed
3) Yoshizaki K Nishimo M, Mihara M et al:Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody. Springer Semin Immunopathol 20:247-259, 1998
 

L Lyme病

P.191 掲載の参考文献
1) 柳原保武, 増澤俊幸, 金田一秀:ライム病 (ライムボレリア症). 最新医 52:37-45, 1997
Medical*Online
2) Steigbigel RT , Benach JL:Immunization against disease-an important first step. N Engl J Med 339:263-264, 1998
PubMed
3) Gardner P:Lyme disease vaccines. Ann Intern Med 129:581-582, 1998
 

M MCTD, UCTD

P.193 掲載の参考文献
1) Smolen JS, Steiner G:Mixed connective tissue disease. To be or not to be. Arthritis Rheum 41:768-777, 1998
 
2) 東條 毅:膠原病重複について想う. リウマチ 38:685-688, 1998
 
3) LeRoy EC, Maricq HR, Kahaleh MB:Undifferentiated connective tissue syndrome. Arthritis Rheum 23:341-343, 1980
PubMed
4) Willams HJ, Alarion GS, Neuner R et al:Eearly undifferentiated connective tissue disease. J Rheumatol 25:261-268, 1998
 
P.195 掲載の参考文献
1) Nelson JL:Maternal-fetal immunology and autoimmune disease. Is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis 39:191-194, 1996
PubMed
2) Nelson JL, Furst DE, Maloney S et al:Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 351:559-562, 1998
PubMed
3) Artlett CM, Smith JB, Jimenez SA:Identification of fetal DNA and cells in skin lesions from women With systemic sclerosis. N Eng J Med 338:1186-1191, 1998
 
4) Evans PC, Lambert N, Maloney S et al:Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 93:2033-2037, 1999
PubMed

N NKT細胞

P.197 掲載の参考文献
1) Makino Y, Koseki H, Adachi Y et al:Extrathymic dfferentiation of a T cell bearing invariant Va14Ja281TCR. Intern Rev immunol 11:31, 1994
 
2) Porcelli SA, Segelke BW, Sugita M et al:The CD1 family of lipid antige-presenting molecules. Immunol Today 19:362-368, 1998
 

S Scleroderma spectrum disorder

P.199 掲載の参考文献
1) Maricq HR LeRoy EC, O'Angelo WA et al:Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 23:183-189, 1980
 
2) Subcommittee for Scleroderma Criteria of the ARA diagnostic and Therapeutic Criteria Committee:Preliminary criteria for the classification of systemic sclerosis (scleroderrna). Arthritis Rheum 23:581-589, 1980
 
3) Ihn H, Sato S, Tamaki T et al:Clinical evaluation of scleroderma spectrum disorders using a points system. Arch Dermatol Res 284:391-395, 1992
PubMed
P.201 掲載の参考文献
1) Bombardier C, Gladman DA, Urowitz MB et al:Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 35:630-640, 1992
 
2) Abrahamowicz M, Fortin PR, du Berger R et al:The relationship between disease activity and expert physician's decision to strat major treatment in active systemic lupus erythematosus:A decision aid for development of entry criteria for clinical trials. J Rheumatol 25:277-284, 1998
 
3) 横張竜一:SLE活動性判定基準. 昭和60年度研究業績集, 厚生省特定疾患自己免疫疾患調査研究班編, 厚生省, 東京, 1986, p. 50
 
P.203 掲載の参考文献
1) Izui S, Merino R, Iwamoto M et al:Mechanisms of genetic control of murine systemic lupus erythematosus Springer Semin Immunopathol 16:133-152, 1994
PubMed
2) Furukawa F:Animal models of cutaneous lupus erythematosus and lupus erythematosus photosensitivity. Lupus 6:193-202, 1997
PubMed
3) Hahn BH:Animal models of systemic lupus erythematosus. In:Dubois' Lupus Erythematosus 5th Edition, ed. by Wallace DJ, Hahn BH, William & Wilkins, Baltimore, 1997, pp. 339-380
 

T T細胞クロナリティー

P.205 掲載の参考文献
1) Davis MM:T cell receptor gene diversity and selection, Annu Rev Biochem 59:475, 1990
PubMed
2) Marguerie C, Lunardi C, So A:PCR-based analysis of the TCR repertoire in human autoimmune diseases. Immunol Today 13:336, 1992
PubMed
3) Pannetier C, Even J, Kourilsky P:T-cell repertoire diversity and clonal expansion in normal and clinical samples. Immunol Today 16:176 , 1995
PubMed
4) Yamamoto K:Significance of antigen-specific T cell clones in collagen diseases:analysis with a novel T cell clonality evaluation system. Intern Med 36:242-247, 1997
PubMed
P.207 掲載の参考文献
1)von Boehwer H:Thymic selection:a matter of life and death. Immunol Today 13:454-458, 1992
 
2) Kruisbeek AM:Tolerance. Immurologist 3:176-179, 1995
 
P.209 掲載の参考文献
1) Clark DA Coker R:Transforming growth factor β(TGF-β). Int Biochem Cell Biol 30:293-298, 1998
 
2) Cotton SA Herrick AL, Jayson MI et al:TGF beta-a role in systemic sclerosis? J Pathol 184:4-6, 1998
PubMed
3) 竹原和彦:汎発性強皮症の病因論-仮説の提唱とその後の展開-. 日臨免疫会誌 20:1-7, 1997
 
P.211 掲載の参考文献
1) Morel PA, Oriss TB:Crossregulation between Th1 and Th2 cells. Crit Rev Immunol 18:275-303, 1998
PubMed
2) Del Prete G:The concept of type-1and type-2 helper T cells and their cytokines in humans. Int Rev Immunol 16:427-455, 1998
 
3) Gately MK, Renzetti LM, Magram J et al:The interleukin-12/interleukin-12-receptor system:role in normal and pathologic immune responses. Annu Rev Immunol 16:495-521, 1998
PubMed

書評

最近チェックした商品履歴

Loading...